| scholarly article | Q13442814 |
| P50 | author | Nicholas P. Restifo | Q51142479 |
| P2093 | author name string | Nicholas P Restifo | |
| P2860 | cites work | Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells | Q24530100 |
| Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells | Q24540135 | ||
| Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells | Q24651232 | ||
| Lineage relationship of effector and memory T cells | Q27026665 | ||
| A human memory T cell subset with stem cell-like properties | Q28248395 | ||
| Host-reactive CD8+ memory stem cells in graft-versus-host disease | Q28281894 | ||
| CD8+ T-cell memory in tumor immunology and immunotherapy | Q34768139 | ||
| T-cell memory differentiation: insights from transcriptional signatures and epigenetics. | Q38076478 | ||
| Purification and characterization of mouse hematopoietic stem cells | Q42065991 | ||
| Lowest numbers of primary CD8(+) T cells can reconstitute protective immunity upon adoptive immunotherapy | Q42214136 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Big Bang | Q323 |
| P304 | page(s) | 476-477 | |
| P577 | publication date | 2014-07-01 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Big bang theory of stem-like T cells confirmed | |
| P478 | volume | 124 |
| Q35980893 | Chimeric antigen receptor-engineered T cells for the treatment of metastatic prostate cancer |
| Q99247595 | Circulation of gut-preactivated naïve CD8+ T cells enhances antitumor immunity in B cell-defective mice |
| Q26796099 | Co-Stimulatory Blockade of the CD28/CD80-86/CTLA-4 Balance in Transplantation: Impact on Memory T Cells? |
| Q40987678 | MHC class II tetramer analyses in AE37-vaccinated prostate cancer patients reveal vaccine-specific polyfunctional and long-lasting CD4(+) T-cells |
| Q92480852 | PD-1 silencing impairs the anti-tumor function of chimeric antigen receptor modified T cells by inhibiting proliferation activity |
| Q40370932 | Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT. |
| Q33578997 | β-catenin and PI3Kδ inhibition expands precursor Th17 cells with heightened stemness and antitumor activity. |
Search more.